Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Strupp

Showing results (341-350 of 360) with videos related to

Pageof 36
Sort By:
Cerebellum (London, England)|June 25, 2015
Consensus Paper: Revisiting the Symptoms and Signs of Cerebellar SyndromeFlorian Bodranghien, Amy Bastian, Carlo Casali, et al.
European Journal of Neurology|June 7, 2021
A cross-sectional, prospective ocular motor study in 72 patients with Niemann-Pick disease type CTatiana Bremova-Ertl, Larry Abel, Mark Walterfang, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Intronic <i>FGF14</i> GAA repeat expansions are a common cause of downbeat nystagmus syndromes: frequency, phenotypic profile, and 4-aminopyridine treatment responseDavid Pellerin, Felix Heindl, Carlo Wilke, et al.
Nature Communications|February 25, 2021
Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microgliaAlessio Colombo, Lina Dinkel, Stephan A Müller, et al.
Ebiomedicine|March 20, 2024
GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohortDavid Pellerin, Felix Heindl, Carlo Wilke, et al.
Neurology. Clinical Practice|February 13, 2018
Recommendations for the detection and diagnosis of Niemann-Pick disease type C: An updateMarc C Patterson, Peter Clayton, Paul Gissen, et al.
BMC Neurology|January 11, 2017
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trialKatharina Feil, Christine Adrion, Julian Teufel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2025
Patient-Derived Neurons Exhibit α-Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial Membrane Protein-Associated NeurodegenerationLeonie M Heger, Leonie Kertess, Clara Kaufhold, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 3, 2023
Intronic <i>FGF14</i> GAA repeat expansions are a common cause of ataxia syndromes with neuropathy and bilateral vestibulopathyDavid Pellerin, Carlo Wilke, Andreas Traschütz, et al.
The New England Journal of Medicine|January 31, 2024
Trial of <i>N</i>-Acetyl-l-Leucine in Niemann-Pick Disease Type CTatiana Bremova-Ertl, Uma Ramaswami, Marion Brands, et al.
Pageof 36

Showing results (341-350 of 360) with videos related to

Sort By:
Pageof 36
Cerebellum (London, England)|June 25, 2015
Consensus Paper: Revisiting the Symptoms and Signs of Cerebellar SyndromeFlorian Bodranghien, Amy Bastian, Carlo Casali, et al.
European Journal of Neurology|June 7, 2021
A cross-sectional, prospective ocular motor study in 72 patients with Niemann-Pick disease type CTatiana Bremova-Ertl, Larry Abel, Mark Walterfang, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Intronic <i>FGF14</i> GAA repeat expansions are a common cause of downbeat nystagmus syndromes: frequency, phenotypic profile, and 4-aminopyridine treatment responseDavid Pellerin, Felix Heindl, Carlo Wilke, et al.
Nature Communications|February 25, 2021
Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microgliaAlessio Colombo, Lina Dinkel, Stephan A Müller, et al.
Ebiomedicine|March 20, 2024
GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohortDavid Pellerin, Felix Heindl, Carlo Wilke, et al.
Neurology. Clinical Practice|February 13, 2018
Recommendations for the detection and diagnosis of Niemann-Pick disease type C: An updateMarc C Patterson, Peter Clayton, Paul Gissen, et al.
BMC Neurology|January 11, 2017
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trialKatharina Feil, Christine Adrion, Julian Teufel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2025
Patient-Derived Neurons Exhibit α-Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial Membrane Protein-Associated NeurodegenerationLeonie M Heger, Leonie Kertess, Clara Kaufhold, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 3, 2023
Intronic <i>FGF14</i> GAA repeat expansions are a common cause of ataxia syndromes with neuropathy and bilateral vestibulopathyDavid Pellerin, Carlo Wilke, Andreas Traschütz, et al.
The New England Journal of Medicine|January 31, 2024
Trial of <i>N</i>-Acetyl-l-Leucine in Niemann-Pick Disease Type CTatiana Bremova-Ertl, Uma Ramaswami, Marion Brands, et al.
Pageof 36